More NewsRead More
Shire and Kamada Announce FDA Approval of Expanded Label for Self-infusion of GLASSIA for the Treatment of Emphysema Due To Severe AAT Deficiency
June 15, 2016
Shire to License PF-00547659 from Pfizer, Adding to Established and Leading Gastrointestinal Portfolio
June 14, 2016
Shire Receives FDA Breakthrough Therapy Designation for SHP621 and SHP625, Investigational Products for Rare Gastrointestinal Conditions
June 13, 2016
Shire Announces Completion of Decentralized Procedure in Europe for Immunoglobulin Treatment Cuvitru
June 10, 2016
12 Biggest Mid-Day Gainers For Wednesday
June 29, 2016
Shire Down 6% Since Brexit, Goldman Sachs Still Bullish
June 28, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here